- Home
- CRIS vs AMOD Comparison
CRIS vs AMOD Comparison
Compare CRIS & AMOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- AMOD
- Stock Information
- Founded
- CRIS 2000
- AMOD 2014
- Country
- CRIS United States
- AMOD United States
- Employees
- CRIS N/A
- AMOD N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- AMOD
- Sector
- CRIS Health Care
- AMOD
- Exchange
- CRIS Nasdaq
- AMOD NYSE
- Market Cap
- CRIS 21.3M
- AMOD 19.2M
- IPO Year
- CRIS 2000
- AMOD N/A
- Fundamental
- Price
- CRIS $1.63
- AMOD $1.08
- Analyst Decision
- CRIS Strong Buy
- AMOD
- Analyst Count
- CRIS 2
- AMOD 0
- Target Price
- CRIS $16.50
- AMOD N/A
- AVG Volume (30 Days)
- CRIS 130.8K
- AMOD 7.5M
- Earning Date
- CRIS 08-05-2025
- AMOD 08-15-2025
- Dividend Yield
- CRIS N/A
- AMOD N/A
- EPS Growth
- CRIS N/A
- AMOD N/A
- EPS
- CRIS N/A
- AMOD 0.12
- Revenue
- CRIS $11,202,000.00
- AMOD N/A
- Revenue This Year
- CRIS N/A
- AMOD N/A
- Revenue Next Year
- CRIS $9.52
- AMOD N/A
- P/E Ratio
- CRIS N/A
- AMOD $9.68
- Revenue Growth
- CRIS 14.17
- AMOD N/A
- 52 Week Low
- CRIS $1.02
- AMOD $1.01
- 52 Week High
- CRIS $8.29
- AMOD $13.49
- Technical
- Relative Strength Index (RSI)
- CRIS 34.22
- AMOD N/A
- Support Level
- CRIS $1.68
- AMOD N/A
- Resistance Level
- CRIS $1.88
- AMOD N/A
- Average True Range (ATR)
- CRIS 0.12
- AMOD 0.00
- MACD
- CRIS -0.01
- AMOD 0.00
- Stochastic Oscillator
- CRIS 17.14
- AMOD 0.00
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About AMOD ALPHA MODUS HOLDINGS INC
Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing, and licensing data-driven technologies to enhance consumers in-store digital experience at the point of decision.